FLI
AZN icon

Family Legacy Inc’s AstraZeneca AZN Stock Holding History

Family Legacy Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-350
Closed -$27K – 113
2018
Q4 		$27K Hold
350
– – 0.02% 131
2018
Q3 		$28K Hold
350
– – 0.02% 131
2018
Q2 		$25K Buy
+350
New +$25.2K 0.02% 131

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Family Legacy Inc's AZN Position: Q1 2019 in Review

Family Legacy Inc sold out of AstraZeneca (AZN) in Q1 2019, closing a stake of 350 shares — an estimated $27K sold.

Family Legacy Inc first reported a position in AZN in Q2 2018 and held it in 3 quarters. The position peaked at $28K in Q3 2018. 561 funds tracked by Wall St. Rank hold AZN as of Q1 2019.

  • Family Legacy Inc reported no remaining AstraZeneca position as of Q1 2019 after selling out during the quarter.
  • Family Legacy Inc sold 350 AstraZeneca shares in Q1 2019, an estimated $27K.
  • Family Legacy Inc first reported a position in AstraZeneca in Q2 2018 and held it in 3 quarters.
  • Family Legacy Inc's AstraZeneca position peaked at $28K in Q3 2018.
  • 561 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2019.

Based on Family Legacy Inc's 13F filing for Q1 2019, filed 6 May 2019.